Does Route of Administration for Estrogen Hormone Therapy Impact Risk of Venous Thromboembolism: Estradiol Transdermal System vs. Oral Estrogen-Only Hormone Therapy

被引：0
|
作者：
Laliberte, Francois [1 ]
Dea, Katherine [1 ]
Duh, Mei Sheng [2 ]
Kahler, Kristijan H. [3 ]
Rolli, Melanie [3 ]
Lefebvre, Patrick [1 ]
机构：
[1] Ltee, Grp Anal, Montreal, PQ, Canada
[2] Anal Grp Inc, Boston, MA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2010年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1224 / 1224
页数：1
相关论文
共 50 条
  • [21] Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study"
    Micheletti, Marie-Christine
    Chevallier, Thierry
    CIRCULATION, 2007, 116 (13) : E362 - E362
  • [22] Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy
    Dix, Caroline
    Moloney, Mollie
    Tran, Huyen A.
    McFadyen, James D.
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (05) : 387 - 398
  • [23] Comparison of continuation of postmenopausal hormone replacement therapy: Transdermal versus oral estrogen
    Ettinger, B
    Pressman, A
    Bradley, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1998, 5 (03): : 152 - 156
  • [24] Could Perimenopausal Estrogen Prevent Breast Cancer? Exploring the Differential Effects of Estrogen-Only Versus Combined Hormone Replacement Therapy
    Manyonda, Isaac
    Talaulikar, Vikram Sinai
    Pirhadi, Roxanna
    Ward, John
    Banerjee, Dibyesh
    Onwude, Joseph
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2022, 14 (01): : 1 - 7
  • [25] Safety of transdermal hormone therapy in menopausal women at increased risk for venous thromboembolism
    Sobel, Talia
    Shen, Wen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1473 - 1474
  • [26] Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer
    Glud, E
    Kjaer, SK
    Thomsen, BL
    Hogdall, C
    Christensen, L
    Hogdall, EI
    Boch, JE
    Blaakaer, J
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (20) : 2253 - 2259
  • [27] Increased risk of recurrent venous thromboembolism (VTE) during hormone replacement therapy (HRT) results of the estrogen in venous thromboembolism trial.
    Hoibraaten, E
    Qvigstad, E
    Arnesen, H
    Larsen, S
    Wickstrom, E
    Sandset, PM
    BLOOD, 1999, 94 (10) : 649A - 649A
  • [28] Does hormone therapy exacerbate other venous thromboembolism risk factors?
    Porterfield, Laura
    Davis, John W.
    Weller, Susan C.
    Chen, Lu
    Wilkinson, Gregg
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (02): : 123 - 129
  • [29] Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy
    Grant, Ellen C. G.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (02) : 232 - 233
  • [30] Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
    Olie, Valerie
    Canonico, Marianne
    Scarabin, Pierre-Yves
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (05) : 457 - 463
12345